The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression
Cancer, Breast, Acupressure, Hematopoiesis
About this trial
This is an interventional supportive care trial for Cancer, Breast focused on measuring Cancer, Acupressure, Hematopoietic Cell Growth Factors
Eligibility Criteria
Inclusion Criteria:
- newly diagnosed of gynecologic cancer, regardless of stage.
- receiving initial chemotherapy.
- ability to write informed consent.
- between 20 to 70 years old.
Exclusion Criteria:
- history of severe cardiac disorder.
- suffering from the hematological diseases such as hemolytic anemia.
- cancer patients with lymphoedema at the area of the acupressure points.
- diagnosed combine with other cancers.
Sites / Locations
- Taipei Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Acupressure group
Control group
The intervention technique used is ''The electric vibrating massager'', ''SAMPO®'', and patients are taught to apply the strong mode on the 15 specific points,5 min each, 3 times a day from Monday to Friday during chemotherapy course. The intervention follows the points are used to stimulate the hematopoietic function. including Hegu (LI4), Quchi (LI11), Xuehai (SP10); Sanyin-jiao (SP6), Taixi (K3), Zusanli (ST36), Taichong (LV3), Baihui (GV20). Before the study, the trained study nurses teach patients that how to use the technique and stuck adhesive dots label on each specific acupoints.
The patients of the control group are not admitted any acupoints press-related interventions, only take clinical treatment protocol as usual.